6215. Cowlserpa (reserpine) tablets, atropine sulfate tablets, digitalis tablets,
and Salamin tablets.    (F.D.C. No. 42435.    S. Nos. 64-348 M, 8-544 P,
8-785 P, 11-955 P.)
INFORMATION FILED: 4-30-59. Disk Mass., against Cowley Pharmaceuticals,
Inc., and Benjamin (Ben) C. Cowley, president, Auburn, Mass.
SHIPPED: Between 7-19-57 and 3-12-58, from Massachusetts to New York
and Michigan.
LABEL IN PART: "1000 Tablets COWLSERPA (Brand of Reserpine) * * *
Distributed and Sold Exclusively by ZIEGLER PHARMACAL CORP.
BUFFALO 2, N.Y. 6531"; "45,000 Tablets ATROPINE SULFATE" [or "5000
TABLETS DIGITALIS RED" or "1000 tablets SALAMIN PAS TIMED DIS-
INTEGRATION] * * * COWLEY PHARMACEUTICALS, INC."
CHARGE: 502(a)-the statements on the labels of the articles, namely,
(Cowlserpa tablets) "Each tablet contains: Reserpine 0.25 mg.," (atropine
sulfate tablets) "Each Tablet contains: Atropine Sulfate ?oo gr.?" and
(digitalis tablets) "Digitalis * * * iy2 gr." were false and misleading since
each Cowlserpa tablet contained less than 0.25 milligram of reserpine, each
atropine sulfate tablet contained less than ?oo grain of atropine sulfate, and
each digitalis tablet contained less than 1? grains of digitalis; and the state-
ment on the label of the Salamin tablets, namely, "Each tablet contains: 0.5
gm. Para-Aminosalicylic Acid Dihydrate For a timed release over a period
of 6-8 hours," was false and misleading since each Salamin tablet failed to
release 0.5 gram of para-aminosalicylic acid in an 8-hour period.
The information alleged also that another product, namely, Metavites tab-
lets, was mis'branded xmder the provisions of the law applicable to foods as
reported in notices of judgment on foods.
PLEA :    Guilty.
DISPOSITION: 5-23-60. Corporation-$500 fine; Cowley-$1,000 fine, $500 of
which was suspended, and probation for 1 year.